NCT00444964View on ClinicalTrials.gov

Growth Hormone Use in Adults With Prader-Willi Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 1, 2012

Study Completion Date

January 1, 2012

Conditions
Prader-Willi Syndrome
Interventions
DRUG

Nutropin AQ

0.0125 mg/kg/day

Trial Locations (1)

64108

The Children's Mercy Hospital, Kansas City

All Listed Sponsors
lead

Children's Mercy Hospital Kansas City

OTHER

NCT00444964 - Growth Hormone Use in Adults With Prader-Willi Syndrome | Biotech Hunter | Biotech Hunter